Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?

For more than 70 years, the contention that high levels of testosterone or that the use of testosterone therapy (TTh) increases the development and progression of prostate cancer (PCa) has been widely accepted and practiced. Yet, the increasing and emerging evidence on testosterone research seems to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, David S., Advani, Shailesh, Tsilidis, Konstantinos K., Wang, Run, Canfield, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503974/
https://www.ncbi.nlm.nih.gov/pubmed/28725600
http://dx.doi.org/10.21037/tau.2017.05.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503974/
https://www.ncbi.nlm.nih.gov/pubmed/28725600
http://dx.doi.org/10.21037/tau.2017.05.35

Ejemplares similares